IMNM
Immunome Inc.
Nasdaq Pharmaceutical Preparations Non-accelerated filer

Key Financials

Operating Income
$-224113000
↑ 26.7%
Revenue
$6.9M
↓ 23.2%
Net Income
$-212394000
↑ 27.5%
EPS (Diluted)
$-2.43
↑ 51.4%
Total Liabilities
$48.8M
↓ 17.3%
Shareholders' Equity
$634.3M
↑ 250.1%
Total Assets
$683.2M
↑ 184.4%
Cash & Equivalents
$653.5M
↑ 355.9%

Recent SEC Filings

Form Type Filed Date Link
SCHEDULE 13G/A 8/14/2026 View on SEC
SCHEDULE 13G/A 8/14/2026 View on SEC
4 8/12/2026 View on SEC
144 8/12/2026 View on SEC
S-8 8/11/2026 View on SEC
10-Q 8/11/2026 View on SEC
8-K 8/11/2026 View on SEC
4 8/10/2026 View on SEC
4 8/6/2026 View on SEC
144 8/6/2026 View on SEC

Company Information

Field Value
Ticker IMNM
Company Name Immunome Inc.
CIK 1472012
Sector Pharmaceutical Preparations
Industry Non-accelerated filer
Exchange Nasdaq
SIC Code 2834
SIC Description Pharmaceutical Preparations
Entity Type operating
Fiscal Year End 1231
State of Incorporation DE
Phone 610-321-3700